HealthCor Catalio Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.
IPO Year:
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
The month of December shows an increasing number of SPAC deal votes. SPAC merger votes can act as a catalyst, as the votes complete the last step in the merger process and change the company over to a new name and ticker that can help build recognition. Several former SPACs also saw wide swings in their share price after being de-SPAC-ed if they receive heavy redemption and have a low float for shares available. December SPAC Merger Calendar: Dec. 1: Aldel Financial Inc (NYSE:ADF) and Hagerty: Auto insurance company Hagerty specializes in providing insurance for classic cars and vehicles. Dec. 2: 890 5th Avenue Partners (NASDAQ:ENFA) and BuzzFeed: Media company BuzzFeed owns brands that i
S-4MEF - HealthCor Catalio Acquisition Corp. (0001833769) (Filer)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
425 - HealthCor Catalio Acquisition Corp. (0001833769) (Subject)
EFFECT - HealthCor Catalio Acquisition Corp. (0001833769) (Filer)
GUILFORD, Conn., Dec. 22, 2021 /PRNewswire/ -- Hyperfine Inc., the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that it has completed its business combination with HealthCor Catalio Acquisition Corp. (NASDAQ:HCAQ) ("HealthCor"), a special purpose acquisition company sponsored by leading healthcare funds HealthCor Management, L.P. and Catalio Capital Management, LP, and Liminal Sciences, Inc. ("Liminal"), a medical device development company dedicated to non-invasive measurement of key vital signs in the brain. Hyperfine will receive approximately $160 million in gross cash proceeds from the business combination
NEW YORK, Dec. 15, 2021 /PRNewswire/ -- HealthCor Catalio Acquisition Corp. (NASDAQ:HCAQ) ("HealthCor") reminds its shareholders to vote at the upcoming extraordinary general meeting of HealthCor's shareholders (the "Special Meeting") on December 21, 2021 to, among other matters, approve the proposed business combination with Hyperfine, Inc. ("Hyperfine") and Liminal Sciences, Inc. ("Liminal") and, in connection therewith, HealthCor's change of domicile to Delaware (the "Domestication"). The affirmative vote of a majority of the ordinary shares of HealthCor voted at the Specia
GUILFORD, Conn., Nov. 29, 2021 /PRNewswire/ -- Hyperfine, Inc. ("Hyperfine"), creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, Liminal Sciences, Inc. ("Liminal"), a medical device development company dedicated to non-invasive measurement of key vital signs in the brain, and HealthCor Catalio Acquisition Corp. ("HealthCor"), a healthcare-focused special purpose acquisition company (SPAC), today announced that the Securities and Exchange Commission ("SEC") has declared the Registration Statement on Form S-4 in connection with the proposed business combination between the companies to be effective.
The transaction will combine Hyperfine, creator of the innovative Portable MR Imaging System, Swoop™, with Liminal Sciences, a medical technology company dedicated to non-invasive brain monitoring, and HealthCor Catalio Acquisition Corp, a healthcare-focused SPAC HealthCor Management, L.P. and Catalio Capital Management teams bring decades of experience investing in private and public healthcare companies This transaction, upon closing, will mark the third public listing of companies founded by Dr. Jonathan Rothberg's 4Catalyzer incubator via SPAC combination this year The transaction is supported by an oversubscribed $126 million PIPE with participation from leading institutional in
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)
4 - Hyperfine, Inc. (0001833769) (Issuer)